Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$16.0 - $20.59 $541,712 - $697,115
-33,857 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$19.16 - $28.09 $2.65 Million - $3.89 Million
-138,434 Reduced 80.35%
33,857 $682,000
Q4 2020

Feb 11, 2021

BUY
$16.4 - $22.9 $2.83 Million - $3.95 Million
172,291 New
172,291 $3.54 Million
Q2 2020

Aug 13, 2020

SELL
$9.41 - $16.94 $2.1 Million - $3.78 Million
-223,430 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$6.88 - $19.7 $1.54 Million - $4.4 Million
223,430 New
223,430 $2.13 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.